INFORMATION:
http://www.aerzteblatt.de/pdf.asp?id=171191
Prostate cancer not caused by shift work
2015-07-24
(Press-News.org) As well as the daily strain of their working lives, shift workers are probably also more likely than other people to develop cancer. While this has been well described for breast cancer, few studies had examined the correlation between shift work and prostate cancer. In a recent original article in Deutsches Ärzteblatt International (Dtsch Arztbl Int 112: 463-70), Gael P. Hammer et al. show that shift workers do not develop prostate cancer more frequently than their colleagues who work during the day.
Shift work is widespread: between approximately one in five and one in six of the working population work shifts. The authors evaluated the personnel and health data of almost 28 000 employees of a chemical company in Rhineland-Palatinate between 1995 and 2005. Some 340 developed prostate cancer, but these included comparable numbers of shift and day workers. This article therefore contradicts the findings of smaller studies, with fewer participants, on the same subject. However, the authors emphasize that their study was the first to analyze the effect of shift work on prostate cancer including such a large number of participants with well documented data.
ELSE PRESS RELEASES FROM THIS DATE:
Object recognition for robots
2015-07-24
CAMBRIDGE, Mass. -- John Leonard's group in the MIT Department of Mechanical Engineering specializes in SLAM, or simultaneous localization and mapping, the technique whereby mobile autonomous robots map their environments and determine their locations.
Last week, at the Robotics Science and Systems conference, members of Leonard's group presented a new paper demonstrating how SLAM can be used to improve object-recognition systems, which will be a vital component of future robots that have to manipulate the objects around them in arbitrary ways.
The system uses SLAM ...
DNA suggests that the diversity of European butterflies could be seriously underestimated
2015-07-24
This news release is available in Spanish.
Since 2006, the team of researchers has sequenced the mitochondrial DNA of all the known species of butterflies in the Iberian peninsula (228) and its main populations. The result is a report that compiles more than 3500 genetic sequences of all the species, which have been compared to the genetic sequences of other European populations. The paper has 277 pages of supplementary material, including pictures and 80 maps of the geographical distribution of the butterfly genetic lineages identified.
This is the first time ...
Temple-led research analyzes impact of case volume on outcomes for DVT treatment
2015-07-24
(Philadelphia, PA) - Patients who have lower extremity proximal deep vein thrombosis (LE-DVT), or a blood clot in their leg, are increasingly undergoing minimally invasive catheter-based blood clot removal - also referred to as catheter-directed thrombolysis (CDT) - rather than solely being treated with traditional blood-thinning medications (anticoagulation alone). This trend is due to recent literature showing reductions in lifestyle-limiting post-thrombotic complications of acute DVT in patients who undergo CDT compared to those that are treated with anticoagulation ...
Toxin from salmonid fish has potential to treat cancer
2015-07-24
This news release is available in German.
Pathogenic bacteria develop killer machines that work very specifically and highly efficiently. Scientists from the University of Freiburg have solved the molecular mechanism of a fish toxin that could be used in the future as a medication to treat cancer. The scientists have now published their research in the journal Nature Communications.
The Yersinia species of pathogens can cause the bubonic plague and serious gastrointestinal infections in humans. The pharmacologist Dr. Thomas Jank and his fellow researchers in the ...
Researchers find new method to halt the advance of liver cancer
2015-07-24
La Jolla, Calif., July 23, 2015 - A new study by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP), the National Cancer Institute, and the Chulabhorn Research Institute has found that blocking the activity of a key immune receptor, the lymphotoxin-beta receptor (LTβR), reduces the progression of liver cancer. The results, published today in the online edition of Gut, could provide new treatment strategies for the disease, which is the third leading cause of cancer-related deaths worldwide.
"Our findings point to a new way to improve the treatment ...
For prostate cancer patients, risk-specific therapies now more the norm
2015-07-24
After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a study by researchers at UC San Francisco.
In the first study to document updated treatment trends, researchers found that from 2010 to 2013, 40 percent of men with low-risk prostate cancer opted for active surveillance, in which the disease is monitored closely with blood tests, imaging studies and biopsies. Treatment is deferred unless these tests show evidence ...
Astronomers discover Earth's bigger cousin
2015-07-24
Today an international team of astronomers from NASA's Kepler mission have announced the discovery of a near-Earth-sized planet in the habitable zone of a Sun-like star.
Dr Daniel Huber from the University of Sydney's School of Physics is part of the team which made the discovery with NASA's Kepler Space Telescope.
The planet named Kepler-452b is 60 per cent larger than Earth and orbits a Sun-like star with an orbital period of 385 days.
The mere 20 day difference between the planet's orbital period and that of Earth's makes it the closest analogue to Earth ever ...
Wind energy provides 8 percent of Europe's electricity
2015-07-24
EU's grid connected cumulative capacity in 2014 reached 129 GW, meeting 8% of European electricity demand, equivalent to the combined annual consumption of Belgium, the Netherlands, Greece and Ireland. According to a JRC report, the impressive growth of the industry will allow at least 12% electricity share by 2020, a significant contribution to the goal of the European energy and climate package of 20% share of energy from renewable sources.
The 2014 JRC wind status report presents the technology, market and economics of the wind energy sector with a focus on the EU. ...
University of York scientists discover why some tumors are resistant to radiotherapy
2015-07-24
Scientists at the University of York believe they have identified how some tiny regulatory molecules in cells can make prostate cancers resistant to radiotherapy.
It is hoped that this new development could pave the way for more effective treatments - allowing a lower dose of radiotherapy to be used while prolonging the lives of thousands of men.
Prostate cancer is the most commonly diagnosed form of male cancer in the UK and kills more than 11,000 men every year.
In the latest studies, published in European Urology and the British Journal of Cancer, scientists in The ...
Patient satisfaction is good indicator of success after spinal surgery
2015-07-24
July 24, 2015 - Patient satisfaction ratings after surgery for spinal degenerative disease--especially in terms of reduced pain and disability--are a good indicator of the procedure's effectiveness, reports a study in the August issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Wolters Kluwer.
"Patient satisfaction with outcome may accurately represent the effectiveness of surgical spine care in terms of one-year improvement in pain and disability," according to the new research by Dr. Clinton J. Devin of Vanderbilt ...